VOYA Investment Management’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-37,434
Closed -$4.5M 2870
2021
Q1
$4.5M Sell
37,434
-6,334
-14% -$917K 0.01% 882
2020
Q4
$5.72M Sell
43,768
-3,978
-8% -$514K 0.01% 772
2020
Q3
$5.04M Buy
47,746
+21,078
+79% +$2.59M 0.01% 743
2020
Q2
$6.86M Buy
26,668
+23,433
+724% +$8.92M 0.02% 644
2020
Q1
$1.44M Buy
3,235
+2,658
+461% +$1.42M ﹤0.01% 1070
2019
Q4
$390K Buy
+577
New +$289K ﹤0.01% 2030

Other funds holding NXTC

VOYA Investment Management's NXTC Position: Q2 2021 in Review

VOYA Investment Management sold out of NextCure (NXTC) in Q2 2021, closing a stake of 37,434 shares — an estimated $4.5M sold.

VOYA Investment Management first reported a position in NXTC in Q4 2019 and held it in 6 quarters. The position peaked at $6.86M in Q2 2020. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • VOYA Investment Management reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 37,434 NextCure shares in Q2 2021, an estimated $4.5M.
  • VOYA Investment Management first reported a position in NextCure in Q4 2019 and held it in 6 quarters.
  • VOYA Investment Management's NextCure position peaked at $6.86M in Q2 2020.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.